Clinical Trials Directory

Trials / Unknown

UnknownNCT03165318

Pulsed Electromagnetic Field (PEMF) Systems to Promote the Maintenance of Bone and Muscle

A Randomized, Sham-Controlled Pilot Study of Pulsed Electromagnetic Field Therapy in Promoting the Maintenance of Muscle Following Anterior Cruciate Ligament (ACL) Reconstruction

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
22 (estimated)
Sponsor
National University Hospital, Singapore · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

This is a pilot study that evaluates the effect of PEMF in maintaining muscle mass postoperatively in individuals experiencing clinical immobilisation due ACL reconstruction surgery. Half of the participants will receive the PEMF therapy in combination with standard rehabilitation programme, while the other half will receive sham therapy in combination with standard rehabilitation programme.

Detailed description

This is a single-site, randomized, double-blinded, prospective pilot study of the effectiveness of once-weekly PEMF therapy in the promotion of muscle maintenance following ACL reconstruction surgery. Eligible subjects will be randomized in a 1:1 ratio to receive therapy with an active PEMF device or an identical inactive Sham device, in addition to the standard rehabilitation regimen.

Conditions

Interventions

TypeNameDescription
DEVICEPulsed Electromagnetic Field TherapyParticipants of this arm will be exposed to 10 minutes of Pulsed Electromagnetic Field (PEMF) once a week for a total of 16 weeks. The PEMF device produces pulsed magnetic fields at flux densities up to 1 mT peak.
DEVICESham TherapyParticipants of this arm will be exposed to 10 minutes of sham therapy once a week for a total of 16 weeks. The Sham device is identical to the PEMF device in physical appearance.

Timeline

Start date
2017-03-07
Primary completion
2018-07-01
Completion
2018-07-01
First posted
2017-05-24
Last updated
2017-05-24

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT03165318. Inclusion in this directory is not an endorsement.